Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Amid regulatory brouhaha, U.S. hedge funds care more about domestic than European and Asian investors

Thursday, March 20, 2014

Komfie Manalo, Opalesque Asia:

Most U.S. hedge fund managers wait for the confusion of rules around the full implementation of the Alternative Investment Fund Managers Directive (AIFMD) so they could market their products in Europe, said Darren Stainrod, a Principal at HighWater Limited at the latest Opalesque 2014 Cayman Roundtable.

"U.S. managers are initially marketing their funds within the U.S. [as they await clarification]," Stainrod said. He added, "In any case the capital flows are largely coming from the U.S., and so there is no need for them to navigate the European minefield or take long flights to Asia,"

He went on to say that in Europe, managers are too distracted by rules and regulations to concentrate on innovation and product development. Stainrod pointed out the AIFMD, EMIR reporting, SEC and CFTC registration, FATCA and a change in UK partnership tax law will keep European managers busy until at least the second half of 2014.

James George, a partner with BDO International in the Cayman Islands, noted that many North American managers do not really have a lot of direct involvement in Europe, so they are either out of scope or they are looking to restructure in order to be out of scope of AIFMD.

BDO is the world’s fifth largest accounting network with offices in 138 countries and employing almost 55,000 peop......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its